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Introduction 
With the profound advances offered the field of infectious diseases 
by advances in immunology, and with the later knowledge that immunologic 
phenomena are not restricted to bacterial substances, it is not surpris¬ 
ing that workers in neoplastic diseases should devote much time and energy 
to the application of these phenomena to cancer. However, despite an 
enormous amount of work, there is as yet no unanimous agreement on the 
fundamental question, "Do specific cancer antibodies exist?" Thus, one 
experienced worker claims (30), "There is no antibody whose existence is 
more definitely proved than those of these antimalignant-cell antibodies," 
xvhile another writer asserts (51) "The demonstration of specific anti¬ 
cancer cell substances in the blood of cancer immune animals is not gen¬ 
erally accepted." In view of the complicated antigenic pattern of neo¬ 
plastic tissue, such disagreement is not surprising. 
The preparation of malignant cells' antibodies according to Mann and 
Welker (34) is hampered by the presence of blood in the tumor antigen. 
This would cause the production of antibodies to the blood proteins as 
well as to the malignant cells. By adsorbing the antigen on to alumina 
and injecting the suspension intramuscularly into rabbits these workers 
prepared antisera in which the blood protein antibody became undetectable, 
\vhile malignant cells' antibody remained. The experiments described here¬ 
in were performed to confirm, and, if possible,extend this vrork. 
Among the workers who have obtained evidence for the existence of 
carcinoma antibodies is Lumsden, who, in 1925 (29), showed that repeated 
injection into rats of mouse tumor tissue produced antisera which pre¬ 
vented in vitro growth of tumor cells, but not that of other tissue cells. 
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Later, he and his associates (32) immunized rats against Jensen rat sar¬ 
coma and found their sera toxic to malignant cells of any variety, while 
harmless to normal tissue. Hirszfeld and Halber (20) found that rabbits 
injected with alcoholic extracts of cancer tissue produced antibodies 
which reacted with more than half of all tumors tested, while these anti¬ 
bodies failed to react with normal tissues. Morelli (39) injected ani¬ 
mals with thyroid cancer, both primary and metastatic to the abdomen, 
and found that the sera of more than half the animals reacted with the 
alcoholic extract of homologous tumor. In one case, the serum reacted 
with extract of mammary carcinoma. Fuchs (12) found that after intra¬ 
venous injection of a cell free tumor antigen, normal persons develop 
an antibody, common to all malignant neoplasms, which gradually disap¬ 
pears from the blood in a few months. Attempting to break down the anti¬ 
genic pattern of malignant tissue into more specific groups, Lehmann- 
Facius (27) found that the phosphatid fraction of carcinoma extract could 
be separated into two parts, one of which was strongly separated by spe¬ 
cific carcinoma phosphatid antiserum, and the other by fatty acid anti¬ 
serum. On the basis of his work, Aron (5) concluded that alcoholic ex¬ 
tract of urine of cancer patients contained an antigenic principle which 
gave a precipitin reaction "when mixed in suitable proportions with sera 
from cancer patients. Trawinski (54) injected saline extracts of fresh 
tumor tissue into rabbits intravenously and produced organ and tumor 
specific precipitins reacting with the antigen, while the sera of rabbits 
immunized with normal tissue did not react with the malignant antigen. 
Working with well standardized animal tumors, Hoyle (23) found that the 
alcoholic extracts of several types gave positive complement-fixation 
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tests with the sera of animals bearing these tumors. The antigen appeared 
to be lipoidal, and was thought to be common for the different tumors. 
Furthermore, the many serological tests for malignant disease, based upon 
antigen-antibody reactions (discussed below), are suggestive enough to af¬ 
ford additional evidence for the existence of these substances. 
On the other hand, other experiments have failed to reveal specific 
malignant cells' antibodies, but indicated the antibody was common to all 
tissues of the particular animal species, and was non-specific for tissue. 
Thus Pybus and Whitehead (44) found that the sera of rabbits immunized 
against mouse carcinoma had a harmful effect in vitro, not only upon 
carcinoma cells, but also upon mouse heart and kidney cells. They also 
found that the serum of a rabbit that had been injected with human carci¬ 
noma supported the growth of carcinomatous cells from mice, although not 
as well as did normal rabbit serum. The growth of normal mouse tissue 
was also inhibited by the same antiserum. Morelli (33, 40) and Witebsky 
and Morelli (56) were unable to confirm a claim (Lehmann-Facius (27)) for 
the separation of a specific antigen for tumor. However, they did find 
that antisera produced by the injection of suspensions of "bone sarcoma" 
reacted with human extracts of sarcoma and carcinoma, and less positively 
with normal tissues. After adsorption with normal extracts, only tumor 
antibodies remained in the serum; all antibodies were gone after subse¬ 
quent adsorption with tumor extracts. Phelps (43) found that both sar¬ 
coma cells and normal spleen cells were killed by antiserum to the Jensen 
rat sarcoma; spleen antiserum behaved the same way. He concluded that 
there was no specific cancer antiserum. Hirzfeld and Halber (21) pro¬ 
duced complement-fixing and precipitin antibodies by injecting rabbits 

Intravenously with extracts of tuberculous caseous tissue, purulent material, 
necrotic tissue from infarcts, and malignant tissue. The antibodies re¬ 
acted with all the antigens, and it was suggested that tumor antibodies 
are the result of necrotic material present in most malignant tissues, 
rather than of any malignant antigen per se. Dmachowski (8) obtained 
rat antiserum which reacted (complement-fixation) with heated tumor anti¬ 
gen, and also, although to a lesser degree, with extracts of normal rat 
tissue. Sera of rabbits immunized against extract of normal rat muscles 
were found to contain antibodies which fixed complement with rat tumor 
even more strongly than with the original antigen. D*Alessandro et al 
(4) are also cited as obtaining reactions between antiserum to the Jensen 
sarcoma and extracts of normal organs. Woodhouse (58) came to the conclu¬ 
sion that there is no proof of the existence of specific carcinoma anti¬ 
gen. 
Most of the disagreement of the two sets of investigations is ap¬ 
parently due to the presence of normal tissue antibodies in sera of ani¬ 
mals injected with extracts of malignant tissue. It would seem likely 
that some normal tissue inevitably is mixed with the tumor antigen, the 
separation of pure malignant tissue from normal tissue being difficult. 
Evidence has accumulated indicating that the species antibodies, pro¬ 
duced by concomitant injections of contaminating normal tissue mixed 
with the tumor antigen, may be separated from the malignant cells’ anti¬ 
bodies, and are not formed in response to pure malignant antigen. 
Lumsden (31) found that the antibodies which were toxic to cancer 
cells were present in the euglobulin fraction of the antiserum, while 
the species antibodies were contained in the pseudoglobulin. Yiitebsky 
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and Poplau (57) concluded that suspensions of saline extracts of carcinoma 
contained three separate antigens - carcinoma, blood, and non-specific. 
They found that while carcinoma antiserum may react with normal organ ex¬ 
tracts, this may be inhibited by lecithin, while the reactivity with mal¬ 
ignant tissue extracts remained unchanged. The antibody adsorption exper¬ 
iments of Morelli, and Witebsky and Korelli, cited above, also indicate 
the separate identities of the species and malignant antibodies. Friedwald 
and Kidd (9), using complement-fixation tests, found that the sera of 
rabbits carrying V2 carcinoma reacted with normal tissue extracts, but 
reacted much more strongly with extracts of V£ carcinoma. Furthermore, 
they showed that heat abolishes the reaction with the normal tissue ex¬ 
tracts, as well as with heterologous tumor antigens, while the reaction 
with the homologous tumor remained unchanged. This antibody was distin¬ 
guishable from the antibody to the papilloma virus. 
Mann and Welker (34) suggested that contaminating species antibodies 
were due to the presence of blood mixed with the tumor antigen. They suc¬ 
ceeded in preparing antisera free from contaminating species antibodies by 
adsorbing the tumor antigen on alumina and injecting the suspension intra¬ 
muscularly into rabbits. ’With this method, the antibodies formed in re¬ 
sponse to the contaminating blood antigens disappeared in one to six months 
leaving only tumor antibodies. This was probably due to the fact that 
blood antigen was present in much smaller quantities than the tumor, and 
was rapidly exhausted from the intramuscular depots of the alumina mixture, 
while appreciable amounts of malignant antigen remained. As a result, 
blood protein antibody production ceased sooner, thereby permitting these 
antibodies to disappear while only tumor antibodies remained in force. 
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These latter antibodies were demonstrated by precipitin reactions with 
an autolyzed antigenic extract; no reaction was obtained with blood pro¬ 
tein after one to six months and normal autolyzed tissue extracts did not 
react either with the antisera. In addition, the antisera reacted with 
a significant number of sera from cancer patients, and not with sera of 
control cases, thus furnishing a basis for a useful diagnostic test. 
The use of alumina as an adsorbent had previously been described 
by Marshall and Welker (35) in 1913* Jacobs (22+) and Seibert (46) demon¬ 
strated that the precipitinogenic power of certain antigens was markedly 
increased after adsorption with alumina. In 1933, Hektoen and Welker 
(16) caused the satisfactory formation of precipitins in the rabbit after 
one intramuscular injection of antigen adsorbed on aluinina. In 1934, the 
same authors (17) showed that when several antigens were adsorbed on alumi¬ 
na, the antibodies formed disappeared from the circulating blood at dif¬ 
ferent times, apparently in proportion to the amount of respective antigen 
injected. Spinka and Weichselbaum (52) applied this technique to tissue 
antigens. They immunized rabbits with ground kidney and liver adsorbed 
on alumina and found that precipitins for blood proteins disappeared in 
one to two months, at which time the antisera continued to react with 
autolysates of the antigenic extract. The work of Mann and Welker appears 
to be an extension of this, using malignant tissue as an antigen. 
( 
-7- 
Material and Methods 
Briefly stated, the methods were as follows: an extract, prepared 
from metastatic thyroid carcinoma, was adsorbed on alumina and injected 
intramuscularly into four rabbits. Their venous blood at intervals of 3-4 
weeks was tested with normal human serum for the presence of blood anti¬ 
bodies. When these had disappeared, the antiserum was then tested with 
autolyzed extract of the original antigen to determine the presence of 
antibodies to this preparation. The sera of the rabbits that were shown 
to be free of blood antibodies and to contain antibodies to the autolyzed 
extract (presumably tumor cell) were then tested with the sera of patients 
with and without malignant disease. 
Preparation of Antigen: 
(1) Tissue. Great difficulty was encountered in procuring a sufficient 
amount of comparatively "pure culture" of malignant tissue; that is, tissue 
that is essentially free of normal tissue, without infection, and with a 
minimum of necrosis. The amount of such material obtainable from surgical 
specimens was negligible. It was finally possible to obtain satisfactory 
antigen from the autopsy material provided by a patient with carcinoma of 
the thyroid with extensive generalized carcinomatosis. The Liver of this 
patient was heavily infiltrated with metastases, and from one slice sixty 
grams of aLmost pure malignant tissue were obtained after careful dissec¬ 
tion (see Appendix). Lundy (33) has reported that metastatic and autopsy 
material furnished good antigens for complement-fixation reactions, and 
Morelli (39) had, in fact, used abdominal metastases from thyroid carcinoma 
to produce satisfactory antibodies in the rabbit. 
After thoroughly dissecting away all normal tissue, the tumor tissue 
was ground in a meat grinder and washed with saline to remove as much blood 

as possible. It was then ground in a ball mill with some saline and a 
small amount of toluol as a preservative for about sixty hours and 
strained through a cheesecloth. The filtrate was washed with saline in 
a centrifuge until the supernatant was biuret negative. The ground tis¬ 
sue was taken up in saline, a few drops of merthiolate, 1:1000, was added, 
and then it was treated with enough alumina to precipitate all the sus¬ 
pension. 
(2) Alumina: The alumina was prepared by slowly adding ~L% ammonium 
hydroxide to a liter of 1% ammonium alum, at room temperature, until the 
liquid yielded a faint odor of ammonia. The resulting precipitate was 
washed several times by decantation with distilled water, filtered, and 
washed until the filtrate was fairly free from salts. It was then trans¬ 
ferred to a glass cylinder and washed again by decantation until 500 cc, 
of the supernatant, evaporated to dryness, left practically no residue. 
After the tumor extract had been adsorbed on to the alumina, this 
was taken up with as much saline as was convenient to permit the use of 
a 17 gauge needle, and injected into the thigh muscles of four rabbits, 
twenty to thirty cubic centimeters into each rabbit, in depots of one to 
two cubic centimeters. 
A portion of the tumor extract was not precipitated with alumina, 
but set aside for tests against the rabbit antisera. This was autolyzed 
by suspending in three times its volume of saline and incubating for 
twenty-four hours at 3S°C. The resulting suspension was then diluted 
with saline up to 1:1000. 
Technique of Tests: The precipitin tests were carried out in tubes made 
by sealing off 7 mm. bore glass tubing. Two tenths of a cubic centimeter 
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of each serum were all that were required for each test, one serum being 
slowly layered over the other. The tubes were left at room temperature 
for an hour, and a positive reaction determined by the presence of a 
thin annular precipitate at the interface between the two sera. 
Preliminary experiments were necessary in order to perfect the 
technique, as it is not difficult to obtain both false negatives and 
false positives by faulty technique. Factors leading to a false positive 
reaction include, first of all, dirty tubes and pipettes. A cloudy emul¬ 
sion easily forms on the glassware, and this may be washed down along 
the sides bjr the test serum, settle at the interface, and give a false 
positive. Although the tubes were left in alkali overnight, rinsed with 
cleaning solution, and thoroughly washed with water under suction, it 
was found advisable not to use the same tube more than three times at 
most. Another source of error lies in the fact that although all sera 
from patients or rabbits were drawn in the fasting state, they were oc¬ 
casionally cloudy. The appearance in the precipitin tube of the sudden 
transition from the cloudy lower layer to clear upper layer almost re¬ 
sembled a positive reaction, and frequent controls with saline were neces¬ 
sary as a check. Occasionally droplets of oil would collect just above 
the interface; these may be distinguished from a true positive because 
they do not assume an annular configuration, and appear above rather than 
at the interface. 
False negative readings are avoided by reading the tubes with a 
strong light shining through, preferably against a dark background. Day 
light, or light of ceiling fixtures, are not sufficiently powerful; a 
desk lamp produces a satisfactory amount of illumination, and this was 
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used. 
The experimental readings (rabbit antiserum with normal human serum 
or with antigen) were done in duplicate, and in every case consistent re¬ 
sults were obtained. The sera for the clinical readings (rabbit antiserum 
against patient's sera) were obtained from the sera sent to the surgical 
chemistry laboratory for analyses. These had all been withdrawn under oil 
in the fasting state. In this way, the diagnoses of the patients were 
unknown to the experimentor, and were learned only after the reading had 
been recorded. These determinations were not done in duplicate because 
of the limitation in the amount of serum. 
Results 
The sera of two of the rabbits injected were tested with normal hu¬ 
man serum for the presence of antibodies of human blood protein. These 
tests were performed by layering the human serum, in dilutions of 1:10 - 
1:1000, over the rabbit antisera as described above. The data in Table I 
demonstrate that precipitins to normal blood proteins disappeared from the 
sera of both rabbits about three months after injection of the antigenic 
preparation. This interval was found to be one to two months by Spinka 
and Wechselbaum (52), and one to six months by Mann and Welker (34). The 
remaining two rabbits died of sepsis a few days after injection (revealed 
by autopsy). 
Having demonstrated the disappearance of contaminating blood anti¬ 
bodies, the antiserum next was tested with the original autolyzed extract 
to detect the presence of antibodies for this preparation. Of the two 
rabbits sera tested one gave a positive precipitin reaction with the ex¬ 
tract, while the other did not. Simultaneous controls of normal human 
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serum, layered over undiluted human serum, to check on error in technique, 
were negative, as were reactions of diluted antigen layered over normal 
human and normal rabbit sera (Tables I and II). 
It may be mentioned that the literature reveals that not many rabbits 
respond with antibody production to the injection of malignant tissue. 
Mann and Welker state, "The percentage of rabbits producing powerful pre¬ 
cipitin antiserum when immunized with malignant tissue is much smaller 
than the percentage that responds when immunized with normal serum proteins". 
Using thyroid tumor, Morelli (39) obtained antibodies in four of seven rab¬ 
bits, and likewise Hirszfeld and Kalber (20) found antibodies in only 10- 
20$ of rabbits injected with alcoholic extracts of cancer tissue. 
Following the apparent demonstration of predpitins to malignant tis¬ 
sue in Rabbit #1, the antiserum of this rabbit was then tested with those 
of patients. In the first tests the antiserum was diluted 1:10; however, 
in the course of the experiments, the rabbit died^and it was necessary to 
dilute to 1:50 its remaining serum so that a few additional tests could 
be performed. It was found that although 1:10 was more satisfactory, posi¬ 
tive results were obtainable with the more dilute antiserum. 
Five of 10 patients with carcinoma proved by biopsy in almost all 
cases reacted positively with the antiserum. A total of 13 tests were per¬ 
formed, with 7 positive results, three patients being tested with both di¬ 
lutions of antiserum. Four of 7 tests with the 1:10 dilution and 3 of 6 
with the 1:50 dilution were positive (Table III). 
One patient with a benign tumor (meningocytic meningioma) also gave 
^Autopsy revealed a fibrinous gray exudate over the epicardium, some cloudy 
white fluid in the pericardial cavity, a flabby myocardium, and a large, 
dilated stomach. 
■*- 
TABLE I 
Disappearance of Normal Human Blood Protein Precipitins from Two Rabbits 
Injected with Antigen (Metastati c Thyroid Carcinoma Adsorbed on Alumina). 
A. Rabbits No. 1 and 2 Injected 11-13-41 
Normal human serum 
1:10 1:100 1:1000 
12“21=41 Undiluted antiserum + + + 
1-24=42 Undiluted antiserum + + + 
2-12-42 Undiluted antiserum - - 
B. Controls 
1-24=42 Undiluted normal - - 
2-12-42 human serum - - 
TABLE II 
Positive Precipitin Reaction in One of Two Rabbits Follovdng Disappearance 
of Human Blood Protein Precipitins. 
Autolyzed Antigenic Suspension 
1:10* 1:100 1:1000 
Rabbit No. 1 (undiluted) ? + 
Rabbit No. 2 » ? 
Normal Rabbit 11 - 
Normal Human " - - 
N.B. All reactions in above tables were performed in duplicate. 
*The suspension was too thick at this dilution for a satisfactory reading 
to be made. 
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a positive reaction. This patient had had a gastrectomy about 2 years 
earlier for a presumed gastric carcinoma, which, however, on pathologi¬ 
cal study proved to be a benign ulcer. 
In all 10 patients without evidence of malignant disease were 
tested, and they were negative; 7 with 1:10 dilution of the antiserum, 
and 4 with 1:50 dilution (one patient was tested with both dilutions). 
These results appear in Table IV. 
Because some workers had reported positive antibody-antigen reac¬ 
tions between tumor extracts and the sera of cancer patients, the 
autolyzed extract was tested against the sera of 9 patients with malig¬ 
nant disease, by layering over these the 1:100 dilution of antigen. All 
of these were negative (Table III). 
Discussion 
The amount of data available from the present experiments are 
hardly sufficient to be considered as a confirmation of the work of Mann 
and Welker although the results tend to lean that way. The few positive 
reactions which were obtained with the human sera were all in tumor pa¬ 
tients, and the results thus appear to justify further work. 
Assuming slight statistical significance to the results, the simplest 
explanation would be that upon which the theory of the experiment is 
based - the injection of the alumina-precipitated malignant tissue re¬ 
sulted in the production of precipitin antibodies in the rabbit, which 
cause the positive reaction with the original antigenic suspension. The 
reaction between the serum of carcinoma patients and the rabbit antiserum 
would, necessitate the assumption of the circulation of malignant antigen 
in the patient's blood. Some evidence for this may be found in the work 

TABLE IV 
Reactions of Sera of Non-Carcinomatous Patients with Rabbit Antiserum 
Case 
No. 
Patient Age Sex Hosp. No. Diagnosis React, with antiserum 
1:10 1:50 
1 A. D. 72 M B24307 Duodenal ulcer 
2 H. K. 65 M B24336R Duodenal ulcer 
3 C. C. 45 F A29221 Pulmonary tbc. 
Small bowel obst. 
due to post-cp 
adhesions 
4 E. M. a F A23010 Cystitis 
Chronic P. I. D. 
5 E. D. 13 F A25566 Perforated appendix - 
6 M. W. 69 M B24849 Perforated gall 
bladder 
7 I. W. 23 M Normal - 
8 C. J. 70 M B13207 Perforated appendix - 
9 J. s. 44 M 67089 Duodenal ulcer 
10 L • 0» 16 F B15568 Nephrotic stage of 
glomerulonephritis 
Pneumococcal peri¬ 
tonitis 
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of Hirszfeld and his associates (22) who found that the serum of rabbits 
immunized with human tumor extracts reacted with extract of livers of 
patients with gastric carcinoma. This v/as interpreted as implying the 
impregnation of the liver with carcinomatous substances, a sort of "bio¬ 
chemical metastasis". Breinl and his associates are cited as obtaining 
similar results (6). 
Other diagnostic tests based upon this principle have been described. 
Gruskin (14), using embryonal cells from fetal mammals injected intra- 
peri toneally into the experimental animals, obtained an antiserum which 
reacted with carcinoma serum. Peretz and Newler (42) used a complement- 
fixation test with carcinoma serum as antigen and the sera of rabbits im¬ 
munized with carcinoma extracts as the source for antibody. With this 
technique, these workers obtained 75/S positives with carcinoma patients, 
and 7.6$ false positives. Fairly good results have been obtained with 
the urine of carcinoma patients as the source of antigen (5), and this 
implies the presence of carcinoma antigen in the circulating blood. Against 
these latter results are the theoretical objection of the difficulty of 
the antigen, presumably of large molecular weight, to pass through the 
renal filter, as well as the experimental results of Sobotka and Bloch 
(50) whose work indicates that the only chemical difference between the 
urine of carcinoma and non-carcinoma patients lies in a higher cholesterol 
level of the former. 
Although the above explanation might be appealing, several serious 
objections may be raised. The precipitin reactions were carried out with 
1:50 dilution of the antiserum. According to Zinsser and Bayne-Jones (3), 
precipitin reactions as known at present, are positive only in low dilu- 
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tions of antiserum, with 1:20 mentioned as a limiting figure. This would 
suggest that all the positive results were due to faulty technique. On 
the other hand, the paper of Mann and Welker mentioned positive precipitin 
reactions between antiserum and normal human blood proteins with dilutions 
of the former as high as 1:100,000. 
The possibility that the precipitins in the rabbit serum were anti¬ 
bacterial and not anti-malignant must be considered - especially as two 
rabbits died within a few days after injection with overwhelming infec¬ 
tions despite the use of merthiolate. This possibility is always present 
when malignant, slightly necrotic (see Appendix) tissue is used. However, 
while the reaction between antigen and antiserum would be explainable, it 
would be difficult to account for the positive reaction between the anti¬ 
serum and carcinoma patients' sera in view of the negative results with 
the controls. More difficult to answer is the work of Hirszfeld and Halber 
(21) indicating that the antigenic properties of malignant tissue are in 
common with those of all necrotic tissue. It may be pointed out, however, 
that several of the negative controls suffered from acute gangrenous pro¬ 
cesses, which, theoretically, should have caused the liberation of as much 
"necrotic antigen" as some of the carcinoma patients. 
The second series of tests, using the antigenic suspension and pa¬ 
tients' antisera, was based upon the possible presence of antibodies to 
malignant tissue in the patient's blood, rather than circulating malig¬ 
nant antigen. These tests were all negative. However, several diagnostic 
tests for carcinoma, based upon this supposition, have been devised by others. 
Some of these have resulted in significant, although not clinically useful, 
results. The technique has usualljr been a complement-fixation test, rather 
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than precipitin, with tumor extract (usually alcoholic, and occasionally 
cholesterolized) as antigen and the patients' sera as antibody. 
In 1903, Simon and Thomas (49) used breast tumor emulsion as antigen 
for complement-fixation tests and obtained suggestive results (65^ positive 
in 37 malignant cases, and 1$ positive in 50 controls). Fry (10, 11) used 
a saline emulsion of the saline insoluble, acetone and alcohol soluble, 
fraction of malignant tissue and obtained about 75!^ correct results. Other 
workers have obtained satisfactoryr results with complement-fixation or 
flocculation tests based upon the above theory (15, 26, 37, 41, 45, 55). 
Less satisfactory results have been obtained by others (13, 28, 36, 47, 43, 
53). 
It is evident that these problems are in an unsettled state, and de¬ 
serve further exploration. The work reported here, though suggestive, is 
of too small volume to help to clarify the subject. 
Summary and Conclusions 
1. Four rabbits were injected intramuscularly with human metastatic thyroid 
carcinoma adsorbed upon alumina. Two rabbits died of infection a few 
days after their injections. 
2. Precipitins to normal human blood serum, demonstrated in the sera of the 
two surviving rabbits, disappeared three months after the injection. 
3. The serum of one of the two rabbits gave a positive precipitin reaction 
with the autolyzed antigen after the human blood precipitins had disap¬ 
peared. 
The serum of this rabbit gave a positive precipitin reaction with the 
sera of 5 of 10 patients suffering with malignant disease. Of 13 tests 
4. 
. 
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performed on such patients, 7 were positive. The presence or absence 
of clinically demonstrable metastases did not appear to affect the re¬ 
sult. 
5. Negative reactions with the antiserum were obtained with serum of all 
10 people without demonstrable cancer. 
6. The single case with a benign tumor (meningioma) reacted positively. 
7. Precipitin reactions between all sera of 9 carcinomatous patients and 
the autolyzed extract were negative. 
8. The small number of experimental animals and tests used in this work 
prevent any definite conclusions from being drawn. 
9. The theoretical aspects and other experimental work in this field are 
discussed. 
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Appendix 
Excerpts from Autopsy Protocol of R. W., Hosp. No. B15824, Autopsy No. 5548. 
Anatomical Diagnosis 
"Carcinoma of thyroid with metastases to mediastinal, axillary, cervi¬ 
cal, retroperitoneal and inguinal lymph nod.es, internal mammary veins, epi- 
cardium, lungs, liver, left kidney and vertebrae. 
"The thyroid has the usual butterfly shape and weighs 28 grams. Ex¬ 
ternal color is much lighter red-brown than usually encountered. When sec¬ 
tioned it is discovered that about 40-50$ of the parenchyma is replaced by 
firm gray, gritty tissue. 
".... in all, the normal thyroid acini have been almost completely re¬ 
placed by neoplastic tissue. The latter is composed of cells with large, 
oval or round variable-sized vesicular nuclei which occasionally contain 
nucleoli; cytoplasm is faintly eosinophilic, scant, and faintly granular. 
LUtotic figures are present but not numerous, there seldom being more than 
two in each high dry (X450) field. For the most part these cells occur in 
solid masses or sheets, without distinctive pattern. Not infrequently, how¬ 
ever, small well'-formed acini are found in the neoplastic tissue. Dense 
fibrous tissue surrounds all foci of the malignant cells. 
"The liver weighs 3900 grams. Its surface is studded with many large 
and small discrete and confluent umbilicated nodules of gray-white tissue ... 
In section, the accumulations of firm white tissue are found to occupy an 
estimated 50-60$ of the bulk of the liver. Centrally, the foreign tissue 
foci are found to be softened with the result that cream-like material can 
be scraped away on the knife blade. 
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"Large sheets and masses of tumor cells are scattered about in a fibrous 
stroma containing proliferating bile ducts ... Several small malignant tissue 
implants removed from the main large nodules are seen scattered throughout 
the parenchyma. One small group of neoplastic cells occupies the lumen of 
a central vein." 
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